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Abstract
Introduction
Reconstruction of HIV transmission links allows to trace the spread and dynamics of infec-
tion and guide epidemiological interventions. The aim of this study was to characterize
transmission networks among subtype B infected patients from Poland.
Material and methods
Maximum likelihood phylogenenetic trees were inferred from 966 HIV-1 subtype B protease/
reverse transcriptase sequences from patients followed up in nine Polish HIV centers.
Monophyletic clusters were identified using 3% within-cluster distance and 0.9 bootstrap
values. Interregional links for the clusters were investigated and time from infection to
onward transmission estimated using Bayesian dated MCMC phylogeny.
Results
Three hundred twenty one (33.2%) sequences formed 109 clusters, including ten clusters of
5 sequences (n = 81, 8.4%). Transmission networks were more common among MSM
(234 sequences, 68.6%) compared to other infection routes (injection drug use: 28 (8.2%)
and heterosexual transmissions: 59 (17.3%) cases, respectively [OR:3.5 (95%CI:2.6–4.6),
p<0.001]. Frequency of clustering increased from 26.92% in 2009 to 50.6% in 2014
[OR:1.18 (95%CI:1.06–1.31),p = 0.0026; slope +2.8%/year] with median time to onward
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transmission within clusters of 1.38 (IQR:0.59–2.52) years. In multivariate models clustering
was associated with both MSM transmission route [OR:2.24 (95%CI:1.38–3.65),p<0.001]
and asymptomatic stage of HIV infection [OR:1.93 (95%CI:1.4–2.64),p<0.0001]. Addition-
ally, interregional networks were linked to MSM transmissions [OR:4.7 (95%CI:2.55–8.96),
p<0.001].
Conclusions
Reconstruction of the HIV-1 subtype B transmission patterns reveals increasing degree of
clustering and existence of interregional networks among Polish MSM. Dated phylogeny
confirms the association between onward transmission and recent infections. High trans-
mission dynamics among Polish MSM emphasizes the necessity for active testing and early
treatment in this group.
Introduction
Scale up of antiretroviral treatment (ART), mother-to-child transmission reduction programs
and earlier introduction of ART have resulted in decreased transmission of new HIV infections
worldwide, especially in Africa and Asia [1,2]. However, in the recent years increase in the
number of the new cases has been observed in high and middle income European countries.
This increase was associated with injection drug use (IDU) in Eastern Europe including
countries such as Russia, Ukraine and Belarus and upsurge of new infections among men-
who-have-sex-with-men (MSM) in West European countries [3,4]. HIV-1 epidemics in
Poland was historically associated with IDU, which was the predominant route of infection
until 2005 [5]. However, in recent years a shift in the dominant transmission route was
observed with a 14-fold increase in the infection frequency among MSM—from 2.5 new diag-
noses per million of male inhabitants in 2000 to 33.8 in 2011 and beyond [6] as well as a 90%
decline in the IDU related transmissions [7]. Currently more than 70% of new diagnoses are
amongst MSM aged 25–34 years [8]. Also, recent models have indicated a high proportion
(68.3%, 95%CI 53.9–76.1%) of undiagnosed HIV among MSM, which is related to low testing
rates in Poland and lack of uniform preventive strategy focused on this group, despite higher
testing rates associated with MSM exposure [9,10].
It has been reported that new infections were associated with inconsistent condom use and
concentrated in the large cities, however, factors driving this epidemics in Poland remain
largely understudied [6]. Across HIV infected populations subtype B remained stably the most
common HIV-1 variant (95.8–86.1%) [11,12] and associated with male gender, MSM trans-
missions, higher CD4 lymphocyte counts and lower HIV plasma viremia at care entry [13,14].
Phylogenetics provides an insight into the HIV network structure including its transmis-
sion dynamics [15]. Use of dated sequence data, coupled with demographic and clinical infor-
mation allows to model characteristics of the epidemics including population-based patterns
of HIV transmission [16]. Dated sequence analyses from cohorts with known and unknown
infection time, showed that early infection was associated with onward transmissions in 25–
50% of cases [17,18,19,20]. For above-mentioned purposes HIV-1 partial pol sequences
obtained from routine genotyping assays have been successfully used. Characterizing popula-
tions forming transmission networks allows to target interventions to the ones at risk. Using
phylogeny relationship between various viral strains may be established with identification of
MSM transmission networks in Poland
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closely interrelated subsets—phylogenetic clusters [19]. Typically, a cluster contains all taxa—
in case of HIV analyses patient derived sequences—descending from the similar lineage or
ancestry [21]. Using these clusters chronology of the spread viral clades spread may be visual-
ized. Typically clusters are defined by the genetic discane between analyzed sequences and/or
statistical support (bootstrap) within the inferred tree [22,23,24]. In HIV medicine clustering
dynamics may reflect changing patient mobility and allows to assess the efficacy of ART as pre-
vention strategy [19,25,26].
Having previously identified common clustering among MSM [13], in this study we wished
to investigate interregional links and time-trends associated with transmission networks for
the HIV-1 subtype B. The aim of this study was to provide insight, based on the phylogenetic
data, into the characteristics and trends in the dynamics of HIV transmission in Poland. We
also aimed to investigate network patterns on the national level to guide HIV prevention.
Materials and methods
Study population and sequencing
For this study 966 HIV-1 subtype B samples collected from patients with defined transmission
route for the purpose of genotypic drug resistance analyses were used. Patients were linked to
care in 9 of 17 Polish HIV treatment centres (Białystok, Bydgoszcz, Gdańsk, Łódź, Kraków,
Poznan, Szczecin, Wroclaw, Zielona Gora). Sequencing was performed at the Clinical Labora-
tory at the Department of Infectious, Tropical Diseases and Acquired Immune Deficiency,
Pomeranian Medical University in Szczecin, Poland.
The samples included sequences collected both from treatment-experienced (n = 176,
18.21%) and antiretroviral-naive (n = 790, 81.87%) patients diagnosed in Poland from 1989 to
2014, prior to the introduction of the antiretroviral treatment. Data for subtype B treatment-
naive patients were partially collected as a part of the Northern-Poland Resistance Transmis-
sion Tracking for HIV-1 (NoRTTH) project funded by the Polish AIDS Society, and the
resistance data were previously published elsewhere [13]. For the molecular clock analyses
sequence sampling dates were used. For individuals with multiple sequences available, the ear-
liest sequence after the positive confirmation HIV test, was included.
The analysed data included: gender, CD4 lymphocyte count and HIV viral load at care
entry, CD4 lymphocyte nadir, age at diagnosis (the age of first positive confirmation test),
HCV co-infection (defined as presence of anti-HCV antibody or HCV-RNA), transmission
route (self-defined by the patient) and CDC clinical stage according to the 1993 classification
system for HIV infection [27] at care entry. As seroconversion time point was often unavail-
able in the source documentation data for the acute HIV infections were not collected—date
of infection was based on the date of the first positive and confirmed HIV test.
The study protocol was approved by the institutional review board named Bioethical Com-
mittee of Pomeranian Medical University in Szczecin (Komisja Bioetyczna Pomorskiego Uni-
wersytetu Medycznego w Szczecinie), Poland (approval number KB-0012/08/12). Research
was conducted in accordance with the Declaration of Helsinki. As the patient data were coded
and anonymous, while all the procedures, including genotyping, are the part of the medical
care on the people living with HIV, no separate written consent was obtained but physicians
informed all subjects on the planned research and checked for verbal non-opposition from
their patients.
Sequencing
HIV RNA extraction, as well as reverse transcriptase and protease genotyping, were performed
using a genotyping assay (Viroseq 2.8, Abbott Molecular, Abbott Park, Illinois, USA)
MSM transmission networks in Poland
PLOS ONE | DOI:10.1371/journal.pone.0172473 February 24, 2017 3 / 15
according to the manufacturer’s protocol. Protease/reverse transcriptase sequences obtained
were 1302 b.p. long; location from the start of HXB2 genome: positions 2253 to 3525. Identifi-
cation of subtype B was performed based on the partial pol sequences using two methods: on-
line software (REGA genotyping 2.0 tool; http://bioafrica.mrc.ac.za/rega-genotype/html/
subtypinghiv.html) and phylogenetic analyses using maximum likelihood (ML) method under
the GTR+γ model with approximate likelihood ratio test (aLRT) (online PHYMLv.3.0-http://
www.atgc-montpellier.fr/phyml) [28]. For reference, sequences with known subtype from
the 2014 version of the HIV sequence compendium (Los Alamos National Laboratory) were
used, supplemented with CRFs from the HIV sequence database (http://www.hiv.lanl.gov/
components/sequence/HIV/search/search.html). All sutype B sequences included in the analy-
sis were assessed for recombination using two methods: a simplot bootscan (2-parameter
Kimura model, window size 200 b.p., 20.p. step) [29] and jumping-profile hidden Markov
model (jpHMM) [30]. Recombinant sequences were removed from the final dataset. Thirty-
seven codon sites associated with protease and reverse transcriptase resistance mutations were
manually deleted from the sequence alignments. The final alignment was 1191 b.p. long.
Identification of clustering
First, clusters were identified using the Maximum Likelihood (ML) method with the NNI-SPR
sub-tree algorithm under the GTR+γ with the PHYML v 3.0 using automatic model selection
[28]. Clustering was assessed by Cluster Picker software with the maximum genetic distances
calculated by the program [31]. Monophyletic clusters were identified with Cluster-picker soft-
ware using 3% within-cluster distance (substitutions/site) threshold and 0.9 aLRT bootstrap
values. Phylogeographic interregional links within the clustered sequences were investigated.
Additionally, for the 321 clustered sequences Bayesian Monte Carlo Marcov Chain
(MCMC) was used. Pooling of clustered sequences was performed for computational reasons.
Three replicates of 35 million generations were run in BEAST v2.3.1 (2015) [32] using a coales-
cent constant population prior and a GTR model with uncorrelated relaxed exponential
molecular clock [33]. This model was cosidered the most fit using phyML modeling. The
molecular clock was calibrated using parameters derived from the phyML analysis, namely
gamma shape: 0.33, estimated proportion of invariant sites with the initial value of 0.5, and the
following GTR substitution rates: AC: 2.621, AG: 7.422, AT: 0.922, GC: 0.943, CT: 14.36, GT:
1.0. Lognormal priors were applied to the coalescent population size, proportion invariants
sites for partitions and clock mean on partitions. All prior and posterior effective sample size
(ESS) values exceeded 200. A consensus tree with posterior probabilities for branch support
was obtained and annotated with TreeAnnotator v 1.5.4 using a 10% burnin. All trees were
visualized in Figtree v.1.2.2.
Time between transmission events was calculated from the dated MCMC tree using dis-
tances between MRCAs for each cluster (internode intervals)—for each identified cluster/pair
the time to the most recent common ancestor (tMRCA) was calculated. Medians and inter-
quartile ranges for these intervals were calculated separately both for all clusters and clusters
5 sequences.
Statistics
Statistical comparisons were performed using Fisher’s exact and Chi2 tests for nominal vari-
ables. Continuous variables were analysed using the Mann-Whitney U-test for nonparametric
statistics (HIV viral load, age at diagnosis, baseline and nadir CD4 lymphocyte counts, inter-
node intervals). Commercial software (Statistica 10PL, Statasoft, Warsaw, Poland) was used
for above statistical calculations. Time trends for the frequency of transmission pairs and
MSM transmission networks in Poland
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clusters were calculated using the logistic regression (R statistical platform version 3.1.0, pack-
age MASS). Two separate analyses (pairs + clusters3 sequences and clusters3 sequences
only) were performed, with presence (coded as 1) or lack of clusters (coded as 0) investigated
for every year. For analyses of time trends in the clustering the 707 (73.2% of the total cohort)
patients diagnosed from 2009–2014 were included, as the sample size for the years 1989–2008
did not exceed 50 sequences. This sample (707 cases) represents 10.8% of the new HIV-1 diag-
noses in Poland for the years 2009–2014 (6560 cases).
Sequence data
Sequences from this study have been submitted to GenBank and may be accessed with the fol-
lowing IDs: KC409158-KC409222, KM057325-KM057372, KM283892-KM284680,
KT340108- KT340205.
Results
Clustering among subtype B infections
Based on the constructed a maximum likelihood phylogenetic tree a total of 109 clusters and
pairs containing 321 (33.2%) sequences were found, including 36 clusters of3 individuals
incorporating 165 (17.1%) sequences (S1 Fig). There were ten clusters of5 sequences
(n = 81, 8.4%), including two larger ones comprising 13 and 20 patients. All these clusters con-
tained only individuals infected by the MSM route (shaded in grey at S1 Fig). Frequency of
transmission pairs and clusters notably increased over time: from 26.92% in 2009 to 50.6% in
2014 [OR: 1.18 (95%CI: 1.06–1.31), p = 0.0026; slope for the frequency increase 2.8%/year].
This trend was similar when sequence pairs were excluded from the clustering analyses
(increase from 9.62% in 2009 to 25.3% in 2014 [OR: 1.21 (95%CI: 1.06–1.38), p = 0.004; slope
for the frequency increase 2.2%/year] (Fig 1).
Clinical characteristics of clustered cases
Univariate associations between clustering and group characteristics are presented in Table 1.
Sequence clusters/pairs were notably more frequent among MSM (229 cases, 71.3%) compared
to other transmission routes (injection drug use (IDU): 32 (10.0%) and heterosexual transmis-
sions: 60 (18.7%) cases, respectively [p<0.001, OR: 3.5 (95%CI: 2.6–4.6)]. Furthermore, clus-
ters (groups of 3 cases) predominantly contained MSM-derived sequences (n = 131, 79.4%)
with only 24 (14.5%) ones from patients infected by heterosexual contact and 10 (6.1%) by
IDUs route. Moreover, patients with sequences forming pairs and clusters were younger at
HIV diagnosis [median: 31 (IQR: 26–37) compared to 32 (27–39) years for unclustered
sequences, p = 0.023], mostly asymptomatic at the time of analysis (67.8%, p<0.001), predomi-
nantly antiretroviral treatment naive (90.0%, p<0.001), and free of hepatitis C virus coinfec-
tion (83.3%, p<0.001). Additionally, CD4 lymphocyte counts at genotyping and CD4
lymphocyte nadirs were significantly higher for clustered/paired patients [baseline CD4
median: 407 (IQR: 209–565) cells/μl versus 290 (111–467) cells/μl, p<0.001 and nadir CD4
median 356 (IQR: 187–493) versus 223 (IQR: 88–383) cells/μl, p<0.001 for paired/clustered
and unclustered sequences, respectively], while HIV viral load was similar across these catego-
ries. Those clinical, immunologic and virologic patterns were similar for clusters of 3 cases
(after removal of sequence pairs from the analysis).
In multivariate analyses of clusters/pairs adjusted for transmission route, gender, clinical
category at diagnosis, antiretroviral treatment history (treated vs. naive) and HCV status the
factors associated with clustering were MSM transmission route [OR: 2.24 (95%CI: 1.38–3.65),
MSM transmission networks in Poland
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p<0.001] and CDC category A [OR: 1.93 (95%CI: 1.4–2.64), p<0.0001]. Similar results were
obtained for clusters of 3 cases with OR: 2.093 (95%CI: 1.14–3.85), p = 0.018 for MSM trans-
missions and OR: 2.64 (95%CI: 1.71–4.04), p<0.0001 for asymptomatic infection at HIV
diagnosis.
Fig 1. Proportions and logistic regression curves over time (2009–2014) for clusters/pairs (A, left) and clusters3 sequences (B, right).
Logistic regression curves are shown over the frequency bars.
doi:10.1371/journal.pone.0172473.g001
Table 1. Demographic, clinical and laboratory cohort characteristics associated with pairs and clusters 3 cases.
Pairs and clusters3
sequences
Unclustered P value Clusters3
sequences
Unclustered P value Total
Male, n (%) 276 (85.98) 515 (79.84) 0.019 152 (92.12) 639 (80.78) <0.001 791 (81.9)
Age at diagnosis, median years (IQR) 31 (26–37) 32 (27–39) 0.023 31 (26–36) 32 (26–39) 0.031 32 (26–39)
CDC HIV infection stage at genotyping, n (%)
Stage A 215 (67.82) 295 (47.12) <0.001 123 (75.93) 387 (49.55) <0.001 510 (54.08)
Stage B 51 (16.09) 139 (22.2) 18 (11.11) 222 (28.43) 190 (20.15)
Stage C 51 (16.09) 192 (30.67) 21 (12.96) 172 (22.02) 243 (25.77)
Dominant transmission route, n (% of the total)
IDU (intravenous drug use) 32 (9.97) 286 (28.68) <0.001 10 (6.06) 207 (25.84) <0.001 217 (22.5)
MSM (men having sex with men) 229 (71.34) 185 (44.34) 131 (79.39) 384 (47.94) 515 (53.3)
HET (heterosexual) 60 (18.69) 174 (26.98) 24 (14.55) 210 (26.22) 234 (24.2)
Lymphocyte CD4+ T cell counts at
genotyping, median (IQR)
407 (209–565) 290 (111–
467)
<0.001 411 (254–638) 307 (117–
475)
<0.001 322 (126–
503)
Nadir lymphocyte CD4+ T cell counts,
median (IQR)
356 (187–493) 223 (88–383) <0.001 354 (209–557) 238 (91–392) <0.001 269 (104–
410)
HIV viral load at genotyping, mean log
copies/ml (SD)
4.80 (±1.0) 4.86 (±1.0) 0.71 4.80 (±0.8) 4.80 (±1.0) 0.68 4.80 (±1.0)
Antiretroviral treatment naive at HIV
genotyping (%)
288 (90.0) 502 (77.83) <0.001 155 (94.51) 635 (80.38) <0.001 790 (81.87)
HCV coinfection 48 (16.67) 221 (37.52) <0.001 17 (11.64) 252 (34.47%) <0.001 608 (69.33)
CDC category available for 943 patients. Data for HCV coinfected for 877 patients.
doi:10.1371/journal.pone.0172473.t001
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Transmission networks
To reflect the dynamics of the HIV transmissions in Poland in recent years we analysed the
transmissions networks among the sites participating in the study. For this purpose the clusters
and pairs containing sequences from patients followed-up at different centers were identified.
Such interregional networks were found in 31 clusters/pairs containing 126 (13%) sequences
from various centers (Fig 2) and were more common among MSM compared to other, trans-
mission routes. In clusters/pairs containing patients from2 centres 112 (11.6%) sequences
Fig 2. Interregional transmission networks identified in the Bayesian MCMC analysis. Line width and shading strength reflects the number of
networks between sites. Provinces participating in the study are shaded in grey.
doi:10.1371/journal.pone.0172473.g002
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were derived from MSM patients compared to four (0.4%) from IDU and 10 (1%) from het-
erosexually infected cases [p<0.001, OR:4.7 (95%CI: 2.55–8.96))]. As expected, frequency of
clusters containing interregional sequences increased notably with the cluster size (OR for
trend: 2.94 (95% CI: 1.51–5.64), p<0.001) (Fig 3).
Time intervals between clustered transmission events
To further investigate phylogenetic relationships between the clusters and pairs dated Bayesian
MCMC phylogeny using a subset of 321 closely related sequences forming clusters and pairs
was reconstructed (marked in blue on the S1 Fig). Median genetic distances for clusters/pairs
were 0.0199 (IQR: 0.013–0.0237) and 0.023 (IQR: 0.0199–0.0276) for clusters 3 sequences.
To reflect the time between transmission events we have inferred a dated tree and calculated
distances between tMRCA and previous nodes [20] for clusters of 3 sequences (Fig 4). Sepa-
rate analysis was performed for clusters of 5 cases (exact topology for the time-scaled phy-
logenies for the clusters 5 shown in Fig 4). Time between the estimated times of infection
for the clusters, reflecting time to onward transmission, ranged from 0.05 to 6.08 years
[median 1.38 (IQR: 0.59–2.52) years]. For clusters of5 sequences the internode intervals
were significantly shorter compared to the smaller clusters [median 1.1 (IQR: 0.43–1.9) years
versus median 2.13 (IQR: 1.1–3.66) years, p = 0.0026, S2 Fig]. Distribution of the internode
Fig 3. Cluster frequencies by size and type of clustering. Intraregional clusters are marked in dark grey, interregional in light grey.
doi:10.1371/journal.pone.0172473.g003
MSM transmission networks in Poland
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Fig 4. Bayesian, time-annotated MCMC phylogenetic tree of the subtype B pol sequences derived from
clustered sequences coloured by cluster size. Clusters sized5 have been enlarged. Branches used for the
internode interval calculations are marked in blue. Posterior probabilities exceeding 0.7 are shown on the tree nodes.
doi:10.1371/journal.pone.0172473.g004
MSM transmission networks in Poland
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distances for the clusters indicates that 22.4% of clustered onward transmissions occurred
within the first 6 months, while 37.6% within the first year from infection; Analyzing only
MSM clusters, the model suggests that the 23.1% and 35.9% of clustered transmissions occur
within the first 6 months and one year from index case infection, respectively. This indicates
that at least 3.9% (7.0% for MSM) of transmissions in the studied group occurred within 6
months and 6.6% (10.9% for MSM) within the first year of infection.
Discussion
In the light of the rising number of new HIV diagnoses, clustered transmissions among MSM
in Europe [4,34] and the shift in the character of epidemics in Poland from injection drug use
related to concentrated, sexually-driven epidemics [6] we focused this study on the phylody-
namic analysis of transmission networks. Data from different centers were analysed to mini-
mize the sampling bias related to the localized epidemics and to reflect countrywide trends in
the molecular epidemiology of HIV-1. The dataset included HIV sequences collected for geno-
typing purposes, and was limited to the subtype B as this clade remains the most prevalent in
the country [11,12,35]. We have shown that the frequency (31%) of clustering is associated
with MSM transmissions and early stage of HIV infection with common (13%) interregional
transmission networks reflecting patient mobility Moreover, it was demonstrated that cluster-
ing is becoming more frequent over time, which indicates the uncontrolled, expanding epi-
demics and forward infections from individuals probably unaware of their HIV status,
especially among MSM populations. This is in line with the surveillance data in Poland with
the rapid increase in new HIV diagnoses in MSM, especially aged 24–34 years. In this group
the number of newly diagnosed infections increased >20 fold, from 13 in the year 2000, to 313
in 2011 [6]. As of the most recent annual report (2013) 68.4% of newly diagnosed infections
with disclosed transmission category were observed in MSM [7]. Clustering may only partially
be explained by the earlier diagnosis during the course of infection over time, as the percentage
of the late presenters reported from the epidemiological data was increasing [7].
Association between MSM transmission route and clustering within the subtype B infected
cases has been previously reported in various cohorts [18,19,25,36,37,38]. Clinical characteris-
tics of the clustered sequences followed the patterns observed in other studies including lack of
prior antiretroviral treatment exposure, higher CD4 lymphocyte counts, earlier stage of HIV
disease and more recent sampling [16,21]. Also observed clustering frequencies were within
the 18.2–60% range observed across European and North-American datasets [16,36,37,39,40]
and similar to the 31.2% observed in SPREAD cohort using the same internode genetic dis-
tance threshold of 3% [41]. Transmission networks observed in our study were not limited to
the single geographical site with 13% of the total analyzed sequences (39.25% of the clustered
ones) dispersed across HIV treatment centers. Of note, this may be associated with clustering
networks, but also reflects the patient migration for personal and professional reasons.
It should be noted, that in the aforementioned SPREAD report, within a much smaller data-
set of 193 Polish sequences from different geographical sites than the current study, a large
cluster of 15 sequences was found. This is consistent with the identification of large, interre-
gional clusters in our analysis including the ones comprising of 13 and 20 sequences. These
large clusters may reflect rapidly growing sub-epidemics [19] and have been found throughout
subtype B infected populations worldwide [38,42,43,44,45], however the exact transmission
pattern within the transmission clusters is difficult to analyze in the cohort of chronically
infected individuals. As expansion of the clusters over time has been reported [19,46] this find-
ing supports the need for early introduction of antiretroviral therapy in populations with fre-
quent clustering aiming to break the transmission chains [47].
MSM transmission networks in Poland
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Additionally, we have modeled the onward transmission time for the clustered infections
indicating that 50% of clustered transmissions occur within 16.5 months after infection, with
25% within 7 months and 75% within 30 months.
Although interval modeling was performed using data inferred from samples with
unknown duration of HIV infection, the results are highly consistent with the ones obtained
for the Dutch observational cohort Athena [18] with reported median time to onward trans-
missions of 17 months (IQR: 7–17 months). Moreover, our data are in accordance to the
study by Lewis et al., indicating that 22.4% (23.1% among MSM) of new infections occurred
within the first 6 months from the index case [20]. Also, our observation that in the clusters
5 sequences 25% percent of transmissions occurred during the first 5.3 months and 50% of
transmissions within the 13.2 months is consistent with the report by Brenner et al., model-
ing that 25%–30% of clustered transmissions occur within 6-months and 50% over a 14- to
17-month period [19].
These data, coupled with the temporal increase in the number of small and larger clusters,
confirms the role of undiagnosed, recently infected individuals in fuelling of the current HIV
epidemics in Poland, similarly to Canada, UK, Netherlands or France [18,19,25,48]. Our
study is expanding the evidence on the enlarging MSM epidemics in Poland with the increas-
ing importance of transmission networks and shows that current molecular dynamics of
HIV spread reflects that of the West-European countries. One of the consequences of
expanding transmission networks may be the increase in frequency of primary drug resis-
tance [42,44], however, we have shown previously that trends in drug resistance were stable
over time, with infrequent transmission within clusters and median prevalence of 8.3%
[13,49]. Given the fact that estimated tMRCA infection times are within the timeframe of
increased frequency of sexually-driven HIV infections observed over the last 10 years we sug-
gest that clustered transmissions may significantly contribute to the current increase in the
prevalence of HIV in Poland. These data are relevant for the design of prophylactic interven-
tions and emphasize the need for prevention programs to focus on early detection and treat-
ment among MSMs as it may reduce the frequency of onward transmissions within the
networks [47,50]. Of note, prevention campaigns targeted to MSM in Poland are currently
limited to anonymous counseling and testing, with no pre-exposure prophylaxis available.
Scarce programs such as "Test and Keep in care"–program targeted at identification and
referral to care for the newly diagnosed patients—do not seem sufficient as testing rates
among populations at risk remain low [51]. The strategy should be "Seek, Test, Link, Treat,
and Retain” as suggested by Hull at al. [52] and may be implemented across all populations,
not only MSM.
Limitation of the study is related to the convenience of sampling—certain proportion of
cases representing intermediate transmissions may have not been indentified and therefore
not included in the analysis. This may result in the overestimation of the transmission inter-
vals. Additionally, the data are limited only to the centers participating in the study—mostly
Western and Southern provinces, however this is the largest sequence dataset available for
the multiple sites in the country. Also, it should be emphasized that sequence datasets are
not sufficient to determine the specific transmission events and ideally should be coupled
with contact information [53]. It should also be noted, that definitions of genetic distance
based clustering are inconsistent across the published studies ranging from 1.5% (most
widely used for recent infections and local cohorts) to 4.5% (chronically infected individuals
from nationwide analyses) [19,25,36,40,54]. We have used the 3% threshold for the inter-
cluster genetic distances proposed by Kaye et al. [44] and used by the European Spread
cohort [41].
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Conclusions
Clustering networks reflect expanding HIV epidemics among MSM in Poland. Interregional
clustering reflects high dynamics of the nationwide HIV epidemics in the MSM group. Pre-
sented molecular data allow to emphasize the need for the evidence-based interventions which
should focus on the proactive identification of populations at the highest risk, testing and early
referral to antiretroviral treatment. Pre-exposure antiretroviral drug use should be imple-
mented as preventive strategy among MSM in Poland as this group contributes significantly to
onward HIV transmissions.
Supporting information
S1 Fig. Maximum likelihood tree showing the indentified clusters marked in blue.
Clusters 5 sequences shaded in grey. All clustered sequences were used for the MCMC anal-
ysis using beast.
(PDF)
S2 Fig. Histograms presenting distributions in time between the dates of infection for the
clustered sequences for all (a) sequences/pairs, (b) clusters 5 sequences, (c) clusters of
2–4.
(TIF)
Acknowledgments
The authors would like to express the gratitude to all of the patients participating in the study.
Author Contributions
Conceptualization: MP MLP AU.
Data curation: MP AU.
Formal analysis: MP AU.
Funding acquisition: MP AU.
Investigation: MP MLP AU MWJ BS JG BK MBJ PS MJ GB AG IML WL KK EG EJ.
Methodology: MP.
Project administration: MP MLP AU.
Resources: MP.
Software: MP.
Supervision: MLP.
Validation: MP.
Visualization: MP.
Writing – original draft: MP MLP AU MWJ BS JG BK MBJ PS MJ GB AG IML WL KK EG
EJ.
Writing – review & editing: MP MLP AU MWJ BS JG BK MBJ PS MJ GB AG IML WL KK
EG EJ.
MSM transmission networks in Poland
PLOS ONE | DOI:10.1371/journal.pone.0172473 February 24, 2017 12 / 15
References
1. Hill A, Pozniak A (2015) HIV treatment cascades: how can all countries reach the UNAIDS 90-90-90 tar-
get? AIDS 29: 2523–2525. doi: 10.1097/QAD.0000000000000864 PMID: 26558548
2. Roehr B (2015) UNAIDS celebrates success in halting spread of HIV and sets goals for 2030. BMJ
351: h3832. doi: 10.1136/bmj.h3832 PMID: 26174322
3. UNAIDS (2013) Global report: UNAIDS report on the global AIDS epidemic http://wwwunaidsorg/sites/
default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_
Report_2013_enpdf.
4. Beyrer C, Sullivan P, Sanchez J, Baral SD, Collins C, Wirtz A,.et al. (2013) The increase in global HIV
epidemics in MSM. AIDS 27: 2665–2678. doi: 10.1097/01.aids.0000432449.30239.fe PMID:
23842129
5. Rosinska M (2006) Current trends in HIV/ AIDS epidemiology in Poland, 1999–2004. Euro surveillance:
bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 11.
6. Rosinska M, Janiec J, Niedzwiedzka-Stadnik M (2013) Increase of new HIV diagnoses among men
who have sex with men in Poland, 2000 to 2011. Euro surveillance: bulletin europeen sur les maladies
transmissibles = European communicable disease bulletin 18: 20642.
7. Niedzwiedzka-Stadnik M, Pielacha M, Rosinska M (2015) HIV and AIDS in Poland in 2013. Przeglad
epidemiologiczny 69: 267–272, 381–264. PMID: 26233085
8. Niedzwiedzka-Stadnik M, Pielacha M, Rosinska M (2014) HIV and AIDS in Poland in 2012. Przeglad
epidemiologiczny 68: 283–289, 383–286. PMID: 25135516
9. Rosinska M, Gwiazda P, DEA D, Presanis AM (2015) Bayesian evidence synthesis to estimate HIV
prevalence in men who have sex with men in Poland at the end of 2009. Epidemiology and infection: 1–
17.
10. Rosinska M, Simmons R, Marzec-Boguslawska A, Janiec J, Porter K (2016) Relating HIV testing pat-
terns in Poland to risky and protective behaviour. AIDS care 28: 423–431. doi: 10.1080/09540121.
2015.1100702 PMID: 26559856
11. Smolen-Dzirba J, Rosinska M, Kruszynski P, Bratosiewicz-Wasik J, Janiec J, Beniowski M, et al. (2012)
Molecular epidemiology of recent HIV-1 infections in southern Poland. Journal of medical virology 84:
1857–1868. doi: 10.1002/jmv.23395 PMID: 23080488
12. Stanczak GP, Stanczak JJ, Marczynska M, Firlag-Burkacka E, Wiercinska-Drapalo A, Leszczyszyn-
Pynka M, et al. (2010) Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years
2000–2008. Journal of medical virology 82: 1291–1294. doi: 10.1002/jmv.21782 PMID: 20513098
13. Parczewski M, Leszczyszyn-Pynka M, Witak-Jedra M, Maciejewska K, Rymer W, Szymczak A, et al.
(2015) Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by
transmission category and subtype. The Journal of antimicrobial chemotherapy 70: 233–242. doi: 10.
1093/jac/dku372 PMID: 25248322
14. Parczewski M, Leszczyszyn-Pynka M, Bander D, Urbanska A, Stanczak G, Boron-Kaczmarska A..
(2010) Characteristics of HIV-1 non-B subtype infections in Northwest Poland. Journal of medical virol-
ogy 82: 1306–1313. doi: 10.1002/jmv.21797 PMID: 20578066
15. Grabowski MK, Redd AD (2014) Molecular tools for studying HIV transmission in sexual networks. Cur-
rent opinion in HIV and AIDS 9: 126–133. doi: 10.1097/COH.0000000000000040 PMID: 24384502
16. Aldous JL, Pond SK, Poon A, Jain S, Qin H, Kahn JS,. (2012) Characterizing HIV transmission networks
across the United States. Clinical infectious diseases: an official publication of the Infectious Diseases
Society of America 55: 1135–1143.
17. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, et al. (2007) High rates of forward
transmission events after acute/early HIV-1 infection. The Journal of infectious diseases 195: 951–959.
doi: 10.1086/512088 PMID: 17330784
18. Bezemer D, van Sighem A, Lukashov VV, van der Hoek L, Back N, Schuurman R. et al. (2010) Trans-
mission networks of HIV-1 among men having sex with men in the Netherlands. AIDS 24: 271–282.
doi: 10.1097/QAD.0b013e328333ddee PMID: 20010072
19. Brenner BG, Wainberg MA (2013) Future of phylogeny in HIV prevention. Journal of acquired immune
deficiency syndromes 63 Suppl 2: S248–254.
20. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ (2008) Episodic sexual transmission of
HIV revealed by molecular phylodynamics. PLoS medicine 5: e50. doi: 10.1371/journal.pmed.0050050
PMID: 18351795
21. Volz EM, Koopman JS, Ward MJ, Brown AL, Frost SD (2012) Simple epidemiological dynamics explain
phylogenetic clustering of HIV from patients with recent infection. PLoS computational biology 8:
e1002552. doi: 10.1371/journal.pcbi.1002552 PMID: 22761556
MSM transmission networks in Poland
PLOS ONE | DOI:10.1371/journal.pone.0172473 February 24, 2017 13 / 15
22. Buonaguro L, Petrizzo A, Tagliamonte M, Vitone F, Re MC, Pilotti E, et al. (2008) Molecular and phylo-
genetic analysis of HIV-1 variants circulating in Italy. Infectious agents and cancer 3: 13. doi: 10.1186/
1750-9378-3-13 PMID: 18847472
23. Hue S, Pillay D, Clewley JP, Pybus OG (2005) Genetic analysis reveals the complex structure of HIV-1
transmission within defined risk groups. Proceedings of the National Academy of Sciences of the United
States of America 102: 4425–4429. doi: 10.1073/pnas.0407534102 PMID: 15767575
24. Leitner T, Escanilla D, Franzen C, Uhlen M, Albert J (1996) Accurate reconstruction of a known HIV-1
transmission history by phylogenetic tree analysis. Proceedings of the National Academy of Sciences of
the United States of America 93: 10864–10869. PMID: 8855273
25. Leigh Brown AJ, Lycett SJ, Weinert L, Hughes GJ, Fearnhill E, Dunn D. (2011) Transmission network
parameters estimated from HIV sequences for a nationwide epidemic. The Journal of infectious dis-
eases 204: 1463–1469. doi: 10.1093/infdis/jir550 PMID: 21921202
26. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver D A,. (2009) Tracing the
HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 6: 49. doi: 10.1186/
1742-4690-6-49 PMID: 19457244
27. (1993) From the Centers for Disease Control and prevention. 1993 revised classification system for HIV
infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA: the
journal of the American Medical Association 269: 460.
28. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. (2010) New algorithms and
methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Sys-
tematic biology 59: 307–321. doi: 10.1093/sysbio/syq010 PMID: 20525638
29. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. (1999) Full-length
human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with
evidence of intersubtype recombination. Journal of virology 73: 152–160. PMID: 9847317
30. Chan PA, Reitsma MB, DeLong A, Boucek B, Nunn A, Salemi M, et al. (2014) Phylogenetic and geos-
patial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island. Infection, genetics
and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 28:
358–366. doi: 10.1016/j.meegid.2014.03.027 PMID: 24721515
31. Ragonnet-Cronin M, Lee BE, Plitt SS, Zahariadis G, Merks H, et al. (2013) Baseline clinical HIV geno-
types are a valid measure of transmitted drug resistance within the treatment-naive population. Journal
of acquired immune deficiency syndromes 64: 443–447. doi: 10.1097/QAI.0b013e3182a4b991 PMID:
24231785
32. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC
evolutionary biology 7: 214. doi: 10.1186/1471-2148-7-214 PMID: 17996036
33. Drummond AJ, Ho SY, Phillips MJ, Rambaut A (2006) Relaxed phylogenetics and dating with confi-
dence. PLoS biology 4: e88. doi: 10.1371/journal.pbio.0040088 PMID: 16683862
34. Vermund SH, Leigh-Brown AJ (2012) The HIV Epidemic: High-Income Countries. Cold Spring Harbor
perspectives in medicine 2: a007195. doi: 10.1101/cshperspect.a007195 PMID: 22553497
35. Parczewski M, Witak-Jedra M, Maciejewska K, Bociaga-Jasik M, Skwara P, Garlicki A, et al. (2014)
Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland. Journal of the Interna-
tional AIDS Society 17: 19753. doi: 10.7448/IAS.17.4.19753 PMID: 25397498
36. Chalmet K, Staelens D, Blot S, Dinakis S, Pelgrom J, Pelgrom J, et al. (2010) Epidemiological study of
phylogenetic transmission clusters in a local HIV-1 epidemic reveals distinct differences between sub-
type B and non-B infections. BMC infectious diseases 10: 262. doi: 10.1186/1471-2334-10-262 PMID:
20822507
37. Chan PA, Hogan JW, Huang A, DeLong A, Salemi M, Mayer KH, et al. (2015) Phylogenetic Investiga-
tion of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men
Who Have Sex With Men. Journal of acquired immune deficiency syndromes 70: 428–435. doi: 10.
1097/QAI.0000000000000786 PMID: 26258569
38. Grossman Z, Avidor B, Mor Z, Chowers M, Levy I, Shahar E, et al. (2015) A Population-Structured HIV
Epidemic in Israel: Roles of Risk and Ethnicity. PloS one 10.
39. Cuevas M, Fernandez-Garcia A, Sanchez-Garcia A, Gonzalez-Galeano M, Pinilla M, Sanchez-Martinez
M, et al. (2009) Incidence of non-B subtypes of HIV-1 in Galicia, Spain: high frequency and diversity of
HIV-1 among men who have sex with men. Euro surveillance: bulletin europeen sur les maladies trans-
missibles = European communicable disease bulletin 14.
40. Yebra G, Holguin A, Pillay D, Hue S (2013) Phylogenetic and demographic characterization of HIV-1
transmission in Madrid, Spain. Infection, genetics and evolution: journal of molecular epidemiology and
evolutionary genetics in infectious diseases 14: 232–239. doi: 10.1016/j.meegid.2012.12.006 PMID:
23291408
MSM transmission networks in Poland
PLOS ONE | DOI:10.1371/journal.pone.0172473 February 24, 2017 14 / 15
41. Frentz D, Wensing AM, Albert J, Paraskevis D, Abecasis AB, Hamouda O, et al. (2013) Limited cross-
border infections in patients newly diagnosed with HIV in Europe. Retrovirology 10: 36. doi: 10.1186/
1742-4690-10-36 PMID: 23551870
42. Brenner BG, Roger M, Moisi DD, Oliveira M, Hardy I, Turgel R, et al. (2008) Transmission networks of
drug resistance acquired in primary/early stage HIV infection. AIDS 22: 2509–2515. doi: 10.1097/QAD.
0b013e3283121c90 PMID: 19005274
43. Brenner BG, Roger M, Stephens D, Moisi D, Hardy I, Weinberg J, et al. (2011) Transmission clustering
drives the onward spread of the HIV epidemic among men who have sex with men in Quebec. The Jour-
nal of infectious diseases 204: 1115–1119. doi: 10.1093/infdis/jir468 PMID: 21881127
44. Kaye M, Chibo D, Birch C (2008) Phylogenetic investigation of transmission pathways of drug-resistant
HIV-1 utilizing pol sequences derived from resistance genotyping. Journal of acquired immune defi-
ciency syndromes 49: 9–16. doi: 10.1097/QAI.0b013e318180c8af PMID: 18667928
45. Little SJ, Kosakovsky Pond SL, Anderson CM, Young JA, Wertheim JO, Mehta SR, et al. (2014) Using
HIV networks to inform real time prevention interventions. PloS one 9.
46. Vega Y, Delgado E, Fernandez-Garcia A, Cuevas MT, Thomson MM, Montero V, et al. (2015) Epidemi-
ological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004–2012: Relevance of
Transmission Clusters in the Propagation of Resistance Mutations. PloS one 10.
47. Wertheim JO, Kosakovsky Pond SL, Little SJ, De Gruttola V (2011) Using HIV transmission networks to
investigate community effects in HIV prevention trials. PloS one 6: e27775. doi: 10.1371/journal.pone.
0027775 PMID: 22114692
48. Frange P, Meyer L, Deveau C, Tran L, Goujard C, Ghosn J, et al. (2012) Recent HIV-1 infection contrib-
utes to the viral diffusion over the French territory with a recent increasing frequency. PloS one 7:
e31695. doi: 10.1371/journal.pone.0031695 PMID: 22348121
49. Parczewski M, Urbanska A, Maciejewska K, Witak-Jedra M, Leszczyszyn-Pynka M (2014) Transmitted
drug resistance to rilpivirine among antiretroviral-naive patients living with HIV from northern Poland.
Journal of the International AIDS Society 17: 18929. doi: 10.7448/IAS.17.1.18929 PMID: 24746180
50. Yeghiazarian L, Cumberland WG, Yang OO (2013) A stochastic multi-scale model of HIV-1 transmis-
sion for decision-making: application to a MSM population. PloS one 8.
51. Rosinska M, Simmons R, Marzec-Boguslawska A, Janiec J, Porter K (2015) Relating HIV testing pat-
terns in Poland to risky and protective behaviour. AIDS care: 1–9.
52. Hull MW, Wu Z, Montaner JS (2012) Optimizing the engagement of care cascade: a critical step to max-
imize the impact of HIV treatment as prevention. Current opinion in HIV and AIDS 7: 579–586. doi: 10.
1097/COH.0b013e3283590617 PMID: 23076123
53. Pennings PS, Holmes SP, Shafer RW (2014) HIV-1 transmission networks in a small world. The Journal
of infectious diseases 209: 180–182. doi: 10.1093/infdis/jit525 PMID: 24151310
54. Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, et al. (2009) A public
health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23:
225–232. doi: 10.1097/QAD.0b013e32831d2a81 PMID: 19098493
MSM transmission networks in Poland
PLOS ONE | DOI:10.1371/journal.pone.0172473 February 24, 2017 15 / 15
